136
A. Avenoza et al. / Tetrahedron: Asymmetry 15 (2004) 131–137
CCH2), 5.71–5.87 (m, 1H, CHC); 13C NMR (CDCl3): d
23.6 (CH3), 34.1 (NCH3), 52.6 (CH2C@C), 56.6 (CH2),
61.1 (NOCH3), 75.2 (CCH3), 116.2 (CH@C), 137.0
(C@CH2); 175.5 (CON); ESIþ ðm=zÞ ¼ 202. Anal. Calcd
4.16. (10R,200R)-Acetic acid 10-[200-hydroxy-200-(methoxy-
methylcarbamoyl)propylcarbamoyl]-10-(phenyl)methyl
ester 11
for C9H18N2O3: C, 53.45; H, 8.97; N, 13.85. Found: C,
(R)-9 (0.20 g, 0.99 mmol) was treated at 30 ꢁC with
Pd(PPh3)4 (0.11 g, 9 · 10À3 mmol) and N,N-dimethyl-
barbituric acid (NDMBA, 0.48 g, 2.95 mmol) in dry
degassed CH2Cl2 (40 mL) with protection from light
under an argon atmosphere. The mixture was stirred
for 3 h, the solvent evaporated and the crude product
treated with saturated Na2CO3 solution (5 mL) and ex-
tracted with CHCl3/isopropanol (3:1) (5 · 20 mL). The
solution was dried over Na2SO4 and the solvent re-
moved to give the crude amino alcohol. The product
was treated at 25 ꢁC with (R)-O-acetylmandelic acid
choride (0.32 g, 1.48 mmol) and TEA (0.15 g, 1.48 mmol)
in CH2Cl2 (20 mL) for 10 h. The reaction mixture was
washed with 5% NaHCO3 solution (5 mL) and the
aqueous layer was extracted with ethyl acetate
(3 · 20 mL); the combined organic layers were dried over
NaSO4, evaporated and purified by column chroma-
tography (hexane/ethyl acetate, 2:8) to give compound
11 as a colourless oil (0.29 g, 0.87 mmol); yield: 88%.
25
53.61; H, 8.89, N, 13.81. Compound (S)-10: ½a )10.2
D
(c 1.19, MeOH); 1H NMR (CDCl3): d 1.33 (s, 3H, CH3),
2.40 (d, 1H, J ¼ 12:3 Hz, CH2), 3.19–3.25 (m, 2H,
NCH2), 3.31 (d, 1H, J ¼ 12:3 Hz, CH2), 3.31–3.39 (m,
2H, NCH2), 5.05–5.20 (m, 4H, 2CCH2), 5.72–5.90 (m,
2H, 2CHC); 13C NMR (CDCl3): d 24.7 (CH3), 41.8
(CH2C@C), 52.5 (CH2C@C), 55.9 (CH2), 74.1 (CCH3),
116.4 (CH@C), 117.0 (CH ¼ C), 134.4 (C@CH2), 136.2
(C@CH2); 176.1 (CON); ESIþ ðm=zÞ ¼ 199. Anal. Calcd
for C10H18N2O2: C, 60.58; H, 9.15; N, 14.13. Found: C,
61.01; H, 9.13, N, 14.09.
4.13. (R)-3-Allylamino-2-hydroxy-N-methoxy-2,N-
dimethylpropionamide (R)-9 and (R)-N-allyl-3-allyl-
amino-2-hydroxy-2-methylpropionamide (R)-10
As described for enantiomers (S)-9 and (S)-10, com-
pounds (R)-9 (0.35 g) and (R)-10 (0.19 g) were obtained
from compound (R)-8 (0.70 g, 2.90 mmol). Overall yield:
½a25 +45.0 (c 0.92, MeOH); 1H NMR (CDCl3): d 1.43 (s,
D
3H, CH3), 2.19 (s, 3H, COCH3), 3.11–3.38 (m, 4H,
NCH3+CH2), 3.72 (s, 3H, NOCH3), 3.90–4.10 (m, 1H,
CH2), 4.67 (s, 1H, OH), 5.98 (s, 1H, CH), 6.55 (br s, 1H,
NH), 7.28–7.55 (m, 5H, Ph); 13C NMR (CDCl3): d 21.3
(COCH3), 23.1 (CH3), 34.0 (NCH3), 46.1 (CH2), 61.4
(NOCH3), 74.6 (CCH3), 76.0 (CH), 127.4, 129.0, 129.3,
135.5 (Ph), 169.0 (NCO), 169.7 (COCH3), 174.1 (CON);
ESIþ ðm=zÞ ¼ 339. Anal. Calcd for C16H22N2O6: C,
56.80; H, 6.55; N, 8.28. Found: C, 56.89; H, 6.51; N,
8.26.
25
93%. Compound (R)-9: ½a +12.2 (c 1.60, MeOH).
D
Anal. Calcd for C9H18N2O3: C, 53.45; H, 8.97; N, 13.85.
Found: C, 53.32; H, 8.96, N, 13.82. Compound (R)-10:
½a
25
D
+10.1 (c 1.19, MeOH). Anal. Calcd for
C10H18N2O2: C, 60.58; H, 9.15; N, 14.13. Found: C,
60.91; H, 9.12, N, 14.10.
4.14. (S)-3-Amino-2-hydroxy-2-methylpropionic acid
(S)-1 (via mesylates)
Allylaminoalcohols (S)-9 and (S)-10 (0.11 g, 0.54 mmol)
were treated at 30 ꢁC with Pd(PPh3)4 (0.06 g,
5 · 10À3 mmol) and N,N-dimethylbarbituric acid
(NDMBA, 0.26 g, 1.61 mmol) in dry degassed CH2Cl2
(30 mL) with protection from light under an argon at-
mosphere. The reaction mixture was stirred for 3 h, the
solvent evaporated and the crude product treated at
60 ꢁC with 6 M aqueous HCl (2 mL) for 8 h. The mixture
was diluted with water (20 mL), washed with ethyl ace-
tate (2 · 10 mL) and concentrated to give the desired
amino acid hydrochloride salt along with N,O-di-
methylhydroxylamine hydrochloride and traces of
NDMBA as impurities. Treatment of this mixture with
4.17. (10R,200S)-Acetic acid 10-[200-hydroxy-200-(methoxy-
methylcarbamoyl)propylcarbamoyl]-10-(phenyl)methyl
ester 12
As described for diastereomer 11, compound 12 (0.15 g,
0.46 mmol, 83%) was obtained from compound (S)-9
25
D
(0.11 g, 0.56 mmol). ½a +34.5 (c 1.57, MeOH); 1H NMR
(CDCl3): d 1.39 (s, 3H, CH3), 2.12 (s, 3H, COCH3), 3.07
(s, 3H, NCH3) 3.19–3.33 (m, 1H, CH2), 3.61 (s, 3H,
NOCH3), 3.98–4.09 (m, 1H, CH2), 4.71 (s, 1H, OH),
6.00 (s, 1H, CH), 6.72 (br s, 1H, NH), 7.18–7.48 (m, 5H,
Ph); 13C NMR (CDCl3): d 21.2 (COCH3), 22.9 (CH3),
33.7 (NCH3), 46.0 (CH2), 61.2 (NOCH3), 74.5 (CCH3),
75.7 (CH), 127.3, 127.7, 128.8, 129.1, 135.8 (Ph), 168.6
(NCO), 169.3 (COCH3), 174.1 (CON); Anal. Calcd for
C16H22N2O6: C, 56.80; H, 6.55; N, 8.28. Found: C,
56.87; H, 6.52; N, 8.30.
ethanol/propylene oxide gave 0.05 g of (S)-1 as a white
25
D
solid yield: 85% ½a +2.9 (c 1.01, H2O). Anal. Calcd for
C4H9NO3: C, 40.33; H, 7.62; N, 11.76. Found: C, 40.24;
H, 7.63; N, 11.72.
4.15. (R)-3-Amino-2-hydroxy-2-methylpropionic acid
(R)-1 (via mesylates)
4.18. (2S,20R)-3-Benzyloxy-2-tert-butoxycarbonylamino-
propionic acid 20-hydroxy-20-(methoxymethyl-
carbamoyl)propyl ester 14
As described for enantiomer (S)-1, compound (R)-1
(0.046 g, 72%) was obtained from a mixture of com-
25
D
pounds (R)-9 and (R)-10 (0.11 g, 0.54 mmol). ½a )2.5
To a solution of (R)-3 (0.13 g, 0.82 mmol), DCC (0.26 g,
0.90 mmol) and DMAP (9 mg, 0.09 mmol) in CH2Cl2
(20 mL) was added a solution of (S)-3-benzyloxy-2-tert-
(c 1.05, MeOH). Anal. Calcd for C4H9NO3: C, 40.33; H,
7.62; N, 11.76. Found: C, 40.10; H, 7.63; N, 11.74.